Skip to Content

Vanguard Health Care Adm VGHAX

Medalist Rating as of | See Vanguard Investment Hub
  • NAV / 1-Day Return 85.31  /  −0.06 %
  • Total Assets 47.4 Bil
  • Adj. Expense Ratio
    0.290%
  • Expense Ratio 0.290%
  • Distribution Fee Level Low
  • Share Class Type Institutional
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment 50,000
  • Status Open
  • TTM Yield 0.84%
  • Turnover 16%

USD | NAV as of Apr 16, 2024 | 1-Day Return as of Apr 16, 2024, 10:15 PM GMT+0

Morningstar’s Analysis VGHAX

Will VGHAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A solid choice for the long run.

Analyst Andrew Redden

Andrew Redden

Analyst

Summary

Vanguard Health Care's impressive team and time-tested approach make it an attractive offering.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings VGHAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 43.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

7.32 3.4 Bil
Healthcare

UnitedHealth Group Inc

6.79 3.2 Bil
Healthcare

AstraZeneca PLC

5.60 2.6 Bil
Healthcare

Merck & Co Inc

4.81 2.2 Bil
Healthcare

Novartis AG Registered Shares

4.67 2.2 Bil
Healthcare

Pfizer Inc

3.70 1.7 Bil
Healthcare

Abbott Laboratories

2.72 1.3 Bil
Healthcare

Danaher Corp

2.55 1.2 Bil
Healthcare

Daiichi Sankyo Co Ltd

2.55 1.2 Bil
Healthcare

Biogen Inc

2.54 1.2 Bil
Healthcare